New cholesterol combo drugs enter human testing
NCT ID NCT07162441
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This early-stage trial is testing two experimental drugs for high cholesterol, called UIC202502 and UIC202505, in 50 healthy adults. The goal is to see how the drugs interact when taken together or alone, and to check for safety. Participants will take each drug separately and then both together over several weeks. This study does not test whether the drugs actually lower cholesterol.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
UIC202502 and UIC202505 (experimental drugs for high cholesterol)
What this could lead to
If successful, this study could help determine safe dosing for future trials of these drugs for high cholesterol.
What could go wrong
This is a very early Phase 1 study in healthy volunteers, not patients. It only looks at drug interaction and safety, not whether the drugs actually treat high cholesterol.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H plus Yangji Hospital
RECRUITINGSeoul, Gwanak-gu, 08779, South Korea
Contact Phone: •••-•••-••••